How large is the prostate health market, and what is its growth trajectory?
The prostate health market size has grown strongly in recent years. It will grow from $34.07 billion in 2024 to $37.34 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to aging population, increased psa screening, rising awareness campaigns, advancements in hormone therapy, growing incidence rates
The prostate health market size is expected to see strong growth in the next few years. It will grow to $53.25 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing adoption of precision medicine, increasing use of ai-driven diagnostics, expansion of targeted radiotherapies, rising demand for minimally invasive treatments, improved genetic profiling for risk assessment. Major trends in the forecast period include AI-powered risk assessment, liquid biopsy advancements, next-generation radiotheranostics, immunotherapy innovations, real-time biomarker monitoring.
Get Your Free Sample of The Global Prostate Health Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21265&type=smp
What are the key forces behind the prostate health market’s growth in recent years?
The rising prevalence of prostate cancer is expected to propel the growth of the prostate health market going forward. Prostate cancer is a type of cancer that occurs when cells in the prostate gland grow uncontrollably, often manifesting as adenocarcinomas, which are the most common form of this disease in men. The rising prevalence of prostate cancer is primarily due to the growing aging population, increased screening practices, and lifestyle factors such as obesity and physical inactivity. Prostate health is essential for the prevention, early detection, and management of prostate cancer. For instance, in January 2023, according to the American Cancer Society (ACS), a US-based, non-profit organization, in 2023, approximately 288,300 new prostate cancer cases were expected to be diagnosed in the U.S., with an estimated 34,700 fatalities resulting from the disease. Therefore, the rising prevalence of prostate cancer will drive the growth of the prostate health market.
What are the major segments of the prostate health market?
The prostate health market covered in this report is segmented –
1) By Disease Indication: Prostate Cancer, Benign Prostate Hyperplasia, Prostatitis
2) By Treatment: Hormonal Therapy, Chemotherapy, Surgical Treatments, Other Treatments
3) By Distribution Channel: E-Commerce Stores, Pharmacies, Other Distribution Channels
Subsegments:
1) By Prostate Cancer: Localized Prostate Cancer, Metastatic Prostate Cancer
2) By Benign Prostate Hyperplasia: Mild BPH, Moderate BPH, Severe BPH
3) By Prostatitis: Acute Bacterial Prostatitis, Chronic Bacterial Prostatitis, Chronic Prostatitis (Non-Bacterial)
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/prostate-health-global-market-report
Which companies dominate the prostate health market?
Major companies operating in the prostate health market are Pfizer Inc., Johnson & Johnson, Siemens Healthineers AG, Bayer AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Genentech Inc., Teleflex Inc., Elekta AB, Myriad Genetics Inc., Freenome, Theragenics Corporation, CureVac BV, ArsenalBio, Roivant Sciences, Artera Inc., Veru Inc., HistoSonics Inc., Immunic Inc., Ezra, Francis Medical, CorTechs Labs, Lucida Medical, Serimmune Inc., Alessa Therapeutics.
What major trends will shape the prostate health market during the forecast period?
Major companies operating in the prostate health market are focusing on technological advancements such as AI-powered risk assessment to gain a competitive edge. AI-powered risk assessment uses artificial intelligence algorithms to analyze data and predict potential risks, helping to make informed decisions and improve outcomes. For instance, in September 2024, Nanostics Inc., a Canada-based clinical-stage biotechnology company, and Protean BioDiagnostics, a US-based biotechnology company, partnered to launch CDX Prostate, a diagnostic tool aimed at men at risk of aggressive prostate cancer. This diagnostic tool utilizes biological data, clinical information, and AI-powered learning models to generate a risk score for aggressive prostate cancer. CDX Prostate employs advanced machine learning algorithms to analyze various biological and clinical data, providing a more accurate risk score for aggressive prostate cancer compared to traditional methods. The test helps healthcare providers and patients make informed decisions about whether to proceed with a biopsy after a high prostate-specific antigen (PSA) test result or an abnormal digital rectal exam (DRE).
What are the key regional dynamics of the prostate health market, and which region leads in market share?
North America was the largest region in the prostate health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Prostate Health Market Report 2025 Offer?
The prostate health market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Prostate health refers to the overall well-being and proper functioning of the prostate gland, a small organ in men that produces seminal fluid. Maintaining prostate health is essential for urinary function, reproductive health, and preventing conditions such as prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Factors influencing prostate health include age, genetics, diet, lifestyle, and regular medical screenings.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21265
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
